5/22/2014 7:38:18 AM
AmpliPhi BioSciences Corporation (OTCBB: APHB), the global leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant infections, announced today that Wendy Johnson has been appointed to its Board of Directors effective May 19, 2014. Ms. Johnson will stand for election to the Board along with AmpliPhi’s other Class 2 directors at the Company’s Annual Meeting on June 27, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by